% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • jjjhenry67 jjjhenry67 Feb 11, 2013 4:44 PM Flag

    Strong upward momentum

    Boston is starting to capture market share from St. Jude who can't launch any new products due to their FDA warning letter. Also profit margins are increasing with Boston now manufacturing their own Promus drug-coated stent rather than having to buy it from Abbott. It looks like being a better year for Boston all round, as I'm also hearing at least 2 of Boston's recent purchases are going to bear fruit. Things seem to be coming right for this company finally.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Medical device maker Boston Scientific Corp said it expects to grow faster than the overall market for implantable heart devices, which has been struggling in recent years amid weak worldwide demand.

      New product launches, improved margins, plus greater participation in emerging markets were among the factors he cited as growth drivers.

      Company executives said there were signs of improvement in the first quarter.

      "We were encouraged but not satisfied," said Chief Financial Officer Jeff Capello, adding that he sees a return to growth in the second half of 2013.

23.72-0.01(-0.04%)Sep 27 4:02 PMEDT